Literature DB >> 11763169

Expression of CD3 and CD11b antigens on blood and mammary gland leukocytes and bacterial survival in milk of cows with experimentally induced Staphylococcus aureus mastitis.

A L Rivas1, F W Quimby, O Coksaygan, A Alba, A Arina, M J Arrobas, R N González, H O Mohammed, D H Lein.   

Abstract

OBJECTIVES: To differentiate early (1 to 8 days) from late (9 to 14 days) inflammatory phases and assess relationships between leukocyte phenotype and bacterial recovery in cows with Staphylococcus aureus-induced mastitis. ANIMALS: 10 first-lactation Holstein cows. PROCEDURE: Blood and milk samples were collected from 4 or 6 cows before and after intramammary infusion of sterile broth or S. aureus, respectively. Flow cytometric expression of CD3 and CD11b antigens on blood and milk leukocytes, leukocyte differential counts, bacterial counts in milk, and somatic cell counts were determined longitudinally.
RESULTS: Density of CD3 molecules decreased on blood lymphocytes and increased on milk lymphocytes after infusion of bacteria. Density of CD11b molecules on lymphocytes and phagocytes and percentage of CD11b+ lymphocytes in milk increased significantly after infusion; maximum values were achieved during the early inflammatory phase. Density of CD3 and CD11b molecules on milk lymphocytes and macrophages, respectively, 1 day after inoculation were negatively correlated with bacterial recovery on day 1 and days 9 to 14, respectively. Density of CD11b molecules on milk macrophages and the ratios of phagocyte to lymphocyte percentages and polymorphonuclear cell to macrophage percentages in milk differentiated the early from the late inflammatory phase. CONCLUSIONS AND CLINICAL RELEVANCE: Activation of bovine mammary gland macrophages and T cells in response to intramammary infusion of S. aureus was associated with an inability to culture this bacterium from milk. Identification of specific inflammatory phases of S. aureus-induced mastitis in cows may allow for the design of more efficacious treatment and control programs.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11763169     DOI: 10.2460/ajvr.2001.62.1840

Source DB:  PubMed          Journal:  Am J Vet Res        ISSN: 0002-9645            Impact factor:   1.156


  5 in total

1.  Effect of intramammary infusion of rbGM-CSF on SCC and expression of polymorphonuclear neutrophil adhesion molecules in subclinical mastitis cows.

Authors:  Tomomi Ozawa; Yoshio Kiku; Megumi Mizuno; Shigeki Inumaru; Shiro Kushibiki; Hiroyuki Shingu; Tomoko Matsubara; Hideyuki Takahashi; Tomohito Hayashi
Journal:  Vet Res Commun       Date:  2011-11-05       Impact factor: 2.459

2.  Multifactorial relationships between intramammary invasion by Staphylococcus aureus and bovine leukocyte markers.

Authors:  Ariel L Rivas; Steven J Schwager; Rubén N González; Fred W Quimby; Kevin L Anderson
Journal:  Can J Vet Res       Date:  2007-04       Impact factor: 1.310

3.  Identification of subpopulations of bovine mammary-gland phagocytes and evaluation of sensitivity and specificity of morphologic and functional indicators of bovine mastitis.

Authors:  A L Rivas; R Tadevosyan; F W Quimby; T Coksaygan; D H Lein
Journal:  Can J Vet Res       Date:  2002-07       Impact factor: 1.310

4.  Feedback-based, system-level properties of vertebrate-microbial interactions.

Authors:  Ariel L Rivas; Mark D Jankowski; Renata Piccinini; Gabriel Leitner; Daniel Schwarz; Kevin L Anderson; Jeanne M Fair; Almira L Hoogesteijn; Wilfried Wolter; Marcelo Chaffer; Shlomo Blum; Tom Were; Stephen N Konah; Prakash Kempaiah; John M Ong'echa; Ulrike S Diesterbeck; Rachel Pilla; Claus-Peter Czerny; James B Hittner; James M Hyman; Douglas J Perkins
Journal:  PLoS One       Date:  2013-02-20       Impact factor: 3.240

5.  Assessing the Dynamics and Complexity of Disease Pathogenicity Using 4-Dimensional Immunological Data.

Authors:  Ariel L Rivas; Almira L Hoogesteijn; Athos Antoniades; Marios Tomazou; Tione Buranda; Douglas J Perkins; Jeanne M Fair; Ravi Durvasula; Folorunso O Fasina; George P Tegos; Marc H V van Regenmortel
Journal:  Front Immunol       Date:  2019-06-12       Impact factor: 7.561

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.